Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

A new analysis found that eating both oily fish and wholemeal/wholegrain bread may help lower one's risk of developing ...

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the disruption of nerve signals and various ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...

People who have been exposed to both PFAS and PCBs are more likely to be diagnosed with multiple sclerosis (MS). These new ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

How Long Does It Take to See a Neurologist? On average, older adults waited 34 days for a new visit to a neurologist after a referral, and nearly 20% waited more than 3 months, new Medicare data ...

Findings show accumulation of neuronal injury and functional decline suggesting that changes in gonadal hormones may be associated with changes in functional and biological markers in MS. HealthDay ...

Tolebrutinib failed to meet the primary endpoint in the phase 3 PERSEUS study involving patients with primary progressive multiple sclerosis.

What should healthcare providers consider when advising patients at risk of or diagnosed with MS regarding the use of exogenous hormones, such as oral contraceptives, and their potential impact on ...

LONDON — Previous research has shown that providing a clinically definite multiple sclerosis (MS) diagnosis often takes several weeks or even months. But new research suggests that a new "technology ...

The first signs of multiple sclerosis (MS) may appear much earlier than most doctors once believed. A new study suggests that changes in healthcare use begin more than a decade before the first clear ...